ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

Corrections Made To NCI Phone Directory

May 17, 1991

Nine Saturation Program Planning Winners Names NCI May Reissue RFP Later This Year

May 23, 1975

NCI Deputy Barker Hits FDA, Calls for New Incentives for Pharmaceutical Industry; Barker Co-Founded Dietary Supplements Firm

May 30, 2003

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

NIC Grants Appeals Process Explained

April 19, 1985